Aspire Private Capital’s Idexx Laboratories IDXX Stock Holding History

Aspire Private Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8	Closed	-$4.04K	–	386
2024 Q3	$4.04K	Hold	8	–	–	﹤0.01%	488
2024 Q2	$3.9K	Hold	8	–	–	﹤0.01%	493
2024 Q1	$4.32K	Hold	8	–	–	﹤0.01%	502
2023 Q4	$4.44K	Hold	8	–	–	﹤0.01%	486
2023 Q3	$3.5K	Hold	8	–	–	﹤0.01%	511
2023 Q2	$4.02K	Hold	8	–	–	﹤0.01%	482
2023 Q1	$4K	Sell	8 -1	-11%	-$479	﹤0.01%	470
2022 Q4	$3.67K	Hold	9	–	–	﹤0.01%	465
2022 Q3	$3K	Hold	9	–	–	﹤0.01%	481
2022 Q2	$3K	Hold	9	–	–	﹤0.01%	454
2022 Q1	$5K	Sell	9 -4	-31%	-$2.1K	﹤0.01%	398
2021 Q4	$9K	Sell	13 -1	-7%	-$628	﹤0.01%	349
2021 Q3	$9K	Hold	14	–	–	﹤0.01%	322
2021 Q2	$9K	Buy	14 +1	+8%	+$552	﹤0.01%	332
2021 Q1	$6K	Buy	13 +8	+160%	+$4.01K	﹤0.01%	365
2020 Q4	$2K	Buy	+5	New	+$2.24K	﹤0.01%	378
2020 Q3	–	Sell	-15	Closed	-$5K	–	483
2020 Q2	$5K	Buy	15 +14	+1,400%	+$4.05K	﹤0.01%	228
2020 Q1	$0	Sell	1 -5	-83%	-$1.3K	﹤0.01%	359
2019 Q4	$2K	Hold	6	–	–	﹤0.01%	378
2019 Q3	$2K	Hold	6	–	–	﹤0.01%	359
2019 Q2	$2K	Buy	+6	New	+$1.48K	﹤0.01%	391

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aspire Private Capital's IDXX Position: Q4 2024 in Review

Aspire Private Capital sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 8 shares — an estimated $4.04K sold.

Aspire Private Capital first reported a position in IDXX in Q2 2019 and held it in 21 quarters. The position peaked at $9K in Q4 2021. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

Aspire Private Capital reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
Aspire Private Capital sold 8 Idexx Laboratories shares in Q4 2024, an estimated $4.04K.
Aspire Private Capital first reported a position in Idexx Laboratories in Q2 2019 and held it in 21 quarters.
Aspire Private Capital's Idexx Laboratories position peaked at $9K in Q4 2021.
1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.